Immunocore (IMCR)
(Delayed Data from NSDQ)
$33.87 USD
+0.47 (1.41%)
Updated Sep 9, 2024 04:00 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Income Statements
Fiscal Year end for Immunocore Holdings PLC Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 249 | 178 | 36 | 39 | 33 |
Cost Of Goods | 1 | 1 | 0 | 0 | 0 |
Gross Profit | 248 | 177 | 36 | 39 | 33 |
Selling & Adminstrative & Depr. & Amort Expenses | 308 | 226 | 222 | 149 | 184 |
Income After Depreciation & Amortization | -60 | -49 | -186 | -111 | -151 |
Non-Operating Income | 4 | 4 | 0 | 3 | 2 |
Interest Expense | 5 | 10 | 8 | 4 | 12 |
Pretax Income | -61 | -55 | -194 | -112 | -161 |
Income Taxes | -6 | -4 | -13 | -17 | -28 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -55 | -51 | -181 | -95 | -133 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -55 | -51 | -181 | -95 | -133 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -56 | -41 | -176 | -99 | -139 |
Depreciation & Amortization (Cash Flow) | 4 | 8 | 10 | 12 | 12 |
Income After Depreciation & Amortization | -60 | -49 | -186 | -111 | -151 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 48.89 | 45.68 | 42.38 | 26.52 | NA |
Diluted EPS Before Non-Recurring Items | -1.13 | -1.09 | -4.19 | -3.58 | NA |
Diluted Net EPS (GAAP) | -1.13 | -1.11 | -4.26 | -3.58 | -0.03 |
Fiscal Year end for Immunocore Holdings PLC Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 75.40 | 70.50 | 70.34 | 65.18 | 59.81 |
Cost Of Goods | 1.71 | 0.25 | -0.57 | 0.28 | 1.11 |
Gross Profit | 73.69 | 70.26 | 70.90 | 64.90 | 58.70 |
SG&A, R&D, and Dept/Amort Expenses | 89.71 | 96.75 | 88.79 | 65.78 | 78.45 |
Income After SG&A, R&D, and Dept/Amort Expenses | -16.02 | -26.49 | -17.89 | -0.88 | -19.75 |
Non-Operating Income | 10.16 | 5.65 | 5.44 | 5.18 | 4.27 |
Interest Expense | 4.28 | 3.24 | -0.84 | 2.07 | 1.96 |
Pretax Income | -10.13 | -24.08 | -25.68 | 2.23 | -17.44 |
Income Taxes | 1.49 | 0.36 | -5.90 | -0.18 | 0.19 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -11.62 | -24.44 | -19.79 | 2.41 | -17.63 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -11.62 | -24.44 | -19.79 | 2.41 | -17.63 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 50.01 | 49.88 | 49.53 | 54.16 | 48.35 |
Diluted EPS Before Non-Recurring Items | -0.23 | -0.49 | -0.40 | 0.04 | -0.37 |
Diluted Net EPS (GAAP) | -0.23 | -0.49 | -0.39 | 0.05 | -0.36 |